Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
Truist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024 outlook, views on capitation, etc. The answers are not verbatim, but we put the company’s answers in their proper context in a give and take format. With this note, we are updating our PT to $28 (previously $32)."